Latest news
Moderna Says Its Norovirus Vaccine Missed an Early Success Threshold, and the Trial Will Continue - Medical DailyMedical Daily · Wed, 05 Aug 2026 11:00:46 GMTNo early success for Moderna’s norovirus vaccine in phase 3 trial - CIDRAPCIDRAP · Mon, 03 Aug 2026 18:09:00 GMTDow Jones Top Company Headlines at 1 AM ET: German Robotics Startup Agile Robots Set to Double Revenue This Year | WestJet ... - BitgetBitget · Mon, 03 Aug 2026 06:54:33 GMTModerna Narrows 2Q Loss, Says New Norovirus Vaccine Didn't Meet Expectations in Late-Stage Trial - MoomooMoomoo · Fri, 31 Jul 2026 11:30:00 GMTModerna Says Norovirus Vaccine Didn’t Meet Statistical Criteria for Early Success in Trial - WSJWSJ · Fri, 31 Jul 2026 07:00:00 GMTMRNA Q2 Earnings Meet, Stock Down on Norovirus Vaccine Setback - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMTModerna Norovirus Vaccine Fails Interim Bar: Trial Extends Into Fourth Season - Tech TimesTech Times · Fri, 31 Jul 2026 07:00:00 GMTModerna slips despite Q2 beat amid trial setback (MRNA:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 07:00:00 GMT